Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CryoCenter is a leading biotechnology company and stem cell bank specializing in the processing, cryopreservation, and therapeutic application of umbilical cord blood and tissue-derived stem cells. Founded in 2002 and based in Moscow, the company operates one of the largest cord blood registries in Eastern Europe and maintains advanced R&D facilities for cell-based regenerative medicine. CryoCenter is actively involved in clinical research, particularly focusing on the use of autologous and allogeneic cord blood cells for treating neurological conditions such as cerebral palsy and autism. Their services include the collection, testing, and long-term storage of hematopoietic and mesenchymal stem cells for both private and public use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CryoCenter.